Collegium Pharmaceutical, Inc.
DE ˙ DB ˙ US19459J1043
26,00 € ↓ -0,80 (-2,99%)
2026-06-03
DEL PRIS
SecurityDE:354 / Collegium Pharmaceutical, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership43,337 shares
Latest Disclosed Value $ 1,433,155
UBS Group AG reports 54.80% decrease in ownership of 354 / Collegium Pharmaceutical, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 43,337 shares of Collegium Pharmaceutical, Inc. (DE:354) valued at $1,196,101 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 95,887 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of -54.80% during the quarter. The current value of the position is $1,126,762 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 43,337 -52,550 -54.80 1,433 -67.72 0.0000
2026-01-29 2025-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 95,887 -159,572 -62.46 4,440 -50.34 0.0001
2025-11-13 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 255,459 24,423 10.57 8,939 30.84 0.0014
2025-08-14 2025-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 231,036 14,505 6.70 6,832 5.69 0.0012
2025-05-13 2025-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 216,531 16,014 7.99 6,463 12.52 0.0012
2025-02-14 2024-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 200,517 164,296 453.59 5,745 310.58 0.0011
2024-11-14 2024-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 36,221 12,948 55.64 1,400 86.78 0.0003
2024-08-14 2024-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 23,273 -8,328 -26.35 749 -38.91 0.0002
2024-05-13 2024-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 31,601 28,428 895.93 1,227 1,163.92 0.0003
2024-02-09 2023-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 3,173 475 17.61 98 61.67 0.0000
2023-11-09 2023-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,698 -8,798 -76.53 60 -75.71 0.0000
2023-08-11 2023-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 11,496 1,685 17.17 247 5.11 0.0001
2023-05-12 2023-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 9,811 7,816 391.78 235 410.87 0.0001
2023-02-08 2022-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 1,995 -1,561 -43.90 46 -19.30 0.0000
2022-11-10 2022-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 3,556 2,667 300.00 57 256.25 0.0000
2022-08-10 2022-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 889 -950 -51.66 16 -56.76 0.0000
2022-05-16 2022-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 1,839 -1,263 -40.72 37 -36.21 0.0000
2022-02-14 2021-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 3,102 -943 -23.31 58 -26.58 0.0000
2021-11-15 2021-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 4,045 -11,846 -74.55 79 -78.99 0.0000
2021-08-13 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 15,891 -3,421 -17.71 376 -17.90 0.0001
2021-05-12 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 19,312 3,961 25.80 458 48.70 0.0002
2021-02-11 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 15,351 10,489 215.73 308 201.96 0.0001
2020-11-12 2020-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 4,862 -14,222 -74.52 102 -69.46 0.0000
2020-07-31 2020-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 19,084 -3,655 -16.07 334 -10.22 0.0001
2020-05-01 2020-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 22,739 -27,522 -54.76 372 -64.02 0.0002
2020-02-14 2019-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 50,261 20,811 70.67 1,034 205.92 0.0004
2019-11-14 2019-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 29,450 26,680 963.18 338 838.89 0.0001
2019-08-14 2019-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,770 -1,850 -40.04 36 -48.57 0.0000
2019-05-14 2019-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 4,620 -3,619 -43.93 70 -50.35 0.0000
2019-02-14 2018-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 8,239 -215 -2.54 141 13.71 0.0001
2018-11-14 2018-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 8,454 -60,564 -87.75 124 -92.47 0.0000
2018-08-14 2018-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 69,018 -132,940 -65.83 1,646 -68.10 0.0007
2018-05-15 2018-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 201,958 51,204 33.97 5,160 85.41 0.0022
2018-02-14 2017-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 150,754 139,824 1,279.27 2,783 2,341.23 0.0011
2017-11-14 2017-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 10,930 -10,374 -48.70 114 -57.30 0.0001
2017-11-14 2017-06-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 21,304 7,537 54.75 267 92.09 0.0001
2017-08-14 2017-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 21,304 7,537 267
2017-11-14 2017-03-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 13,767 10,174 283.16 139 148.21 0.0001
2017-05-12 2017-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 13,767 10,174 139
2017-02-14 2016-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 3,593 175 5.12 56 -15.15 0.0000
2016-11-14 2016-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 3,418 418 13.93 66 83.33 0.0000
2016-08-12 2016-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 3,000 -1,500 -33.33 36 -56.10 0.0000
2016-05-12 2016-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 4,500 2,208 96.34 82 30.16 0.0001
2016-02-16 2015-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,292 1,792 358.40 63 472.73 0.0000
2015-11-13 2015-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 500 500 11 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.